SkyePharma AG

Industry · 10 registered clinical trials.

Status	Trial	Phase	Started
Unknown	The Gastric Residence Time (GRT) of Soctec Capsule After a Standardized Breakfast Healthy	EARLY_Phase 1	2014-09-01
Completed	A Phase 3, Multicenter, Open-label Continuation Study in Moderate to Severe Asthmatic Subjects Who Completed F Asthma	Phase 3	2008-09-01
Completed	Single-dose Crossover Study to Evaluate the Early Bronchodilating Effect of FlutiForm HFA pMDI in Adult Subjec Mild to Moderate Asthma	Phase 2	2008-09-01
Completed	A Phase I Study in Asthma Patients Evaluating the Effect of Doses of FlutiForm™ on the Amount, if Any, of Cort Asthma	Phase 1	2008-04-01
Completed	A Study Comparing the Safety and Efficacy of Fluticasone and Formoterol Combination (FlutiForm™) With Fluticas Asthma	Phase 3	2008-03-01
Completed	Comparison of New Combination Inhaler (FlutiForm HFA MDI 100/10 µg) Versus Fluticasone and Formoterol Administ Asthma	Phase 3	2006-07-01
Completed	Comparison of New Combination Inhaler (FlutiForm HFA MDI 100/10 µg) Versus Fluticasone & Formoterol Administer Asthma	Phase 3	2006-06-01
Completed	New Combination Inhaler (FlutiForm HFA MDI 100/10 µg and 250/10 µg) Versus Fluticasone and Formoterol Administ Asthma	Phase 3	2006-06-01
Completed	New Combination Inhaler (FlutiForm HFA MDI 100/10 µg and 250/10 µg) in Patients With Asthma Asthma	Phase 3	2006-03-01
Completed	Single-dose Crossover Study to Compare the Safety and Efficacy of FlutiForm With Fluticasone and Formoterol Co Asthma	Phase 2	2004-10-01